Press Releases

Robust sales of Aurora Dissolve Strips validate unique product characteristicsWork underway to expand product offering for medical and recreational markets HAMILTON, ON, Dec 23, 2019 /PRNewswire/ - CTT Pharmaceutical Holdings, Inc., (the "Company" or "CTT") (OTC: CTTH), an innovative life sciences company with a

LANSING, Mich., Dec. 23, 2019 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that its revenues for the second quarter of its 2020 fiscal year, which ended Nov. 30, were $107,803,000, compared to the previous year's second quarter revenues of $107,098,000. Cur

CARLSBAD, Calif., Dec. 23, 2019 /PRNewswire/ -- Patient Power®, which delivers patient-powered journalism, information and opportunities to engage with and connect to the cancer community, reports that research and scientific advances across many blood cancers, presented at the American Society of Hematology (ASH) Annual Meeting, offe

NEW YORK, Dec. 23, 2019 /PRNewswire/ -- The Mesothelioma Victims Center says, "We are appealing to a person with mesothelioma or their family members to call us anytime at

SAN RAFAEL, Calif., Dec. 23, 2019 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that the company submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for its investigational AAV gene therapy, valoctocogene roxaparvovec, for adults with hemophilia A.  Subject to completion of the FDA's filin

SAN DIEGO, Dec. 23, 2019 /PRNewswire/ -- Former NFL player, Wes Chandler, a member of the San Diego Chargers Hall of Fame, and most recently an inductee into the College Football Hall of Fame, announced today the formation of a biotechnology company named WCTE Inc. which is dedicated to the diagnosis, intervention, and cure of Chronic Traum

PLANTATION, Fla., Dec. 23, 2019 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF) is grateful for its partners whose financial support helped make 2019 a huge success. These sponsors have made significant contributions toward the organization's mission-driven initiatives, including its Patient Resource Education Program (PREP), stomach cancer sy

SAN RAFAEL, Calif., Dec. 23, 2019 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that the European Medicines Agency (EMA) validated the Company's Marketing Authorization Application (MAA) for its investigational gene therapy, valoctocogene roxaparvovec, for adults with severe hemophilia A.  The MAA review will commence in

SOUTH SAN FRANCISCO, Calif., Dec. 23, 2019 /PRNewswire/ -- Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced that it will host an investor event to discuss expected corporate and product milestones in 2020. The event is scheduled to take place on Tuesday, January 14, at 7 a.m. PT

ATLANTA, Dec. 23, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received authorization from the U.S. Food and Drug Administration (FDA) pursuant to an Investigational New Drug (IND) application to begin the PROACT Xa clinical trial, a prospective, randomiz